(Q39670669)

13 September 2017

title

Functional divergence between 2 chemokines is conferred by single amino acid change (English)

1 reference

13 September 2017

1

Alexandre Dubrac

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20688960

17 June 2024

3

Eric Lacazette

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20688960

17 June 2024

author name string

Cathy Quemener

2

1 reference

13 September 2017

Fréderic Lopez

4

1 reference

13 September 2017

Catherine Zanibellato

5

1 reference

13 September 2017

Wen-Guey Wu

6

1 reference

13 September 2017

Andréas Bikfalvi

7

1 reference

13 September 2017

Hervé Prats

8

1 reference

13 September 2017

language of work or name

English

0 references

publication date

5 August 2010

1 reference

13 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Blood

1 reference

13 September 2017

volume

116

1 reference

13 September 2017

issue

22

1 reference

13 September 2017

page(s)

4703-4711

1 reference

Angiogenesis in life, disease and medicine

13 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Chemokines and chemokine receptors: an overview.

17 June 2024

2

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Chemokine: receptor structure, interactions, and antagonism

17 June 2024

3

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Heparan sulphate proteoglycans: the sweet side of development

17 June 2024

4

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Heparin and heparan sulfate: biosynthesis, structure and function

17 June 2024

5

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Chemokines as mediators of neovascularization

17 June 2024

6

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Platelet factor 4 gene transfection into tumor cells inhibits angiogenesis, tumor growth and metastasis.

17 June 2024

7

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Cancer CXC chemokine networks and tumour angiogenesis

17 June 2024

8

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2

17 June 2024

11

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

New insights into the molecular interaction of the C-terminal sequence of CXCL4 with fibroblast growth factor-2.

17 June 2024

12

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma.

17 June 2024

13

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

The CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis

17 June 2024

14

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4

17 June 2024

15

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis.

17 June 2024

16

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

PF-4/CXCL4 and CXCL4L1 exhibit distinct subcellular localization and a differentially regulated mechanism of secretion

17 June 2024

17

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Antiangiogenic properties of fibstatin, an extracellular FGF-2-binding polypeptide

17 June 2024

18

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Translational induction of VEGF internal ribosome entry site elements during the early response to ischemic stress.

17 June 2024

19

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity.

17 June 2024

20

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Recombinant platelet factor 4 for heparin neutralization

17 June 2024

23

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

A surface plasmon resonance-based solution affinity assay for heparan sulfate-binding proteins

17 June 2024

24

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4/CXCL4 and potent inhibitor of angiogenesis.

17 June 2024

25

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Reversal of heparin anticoagulation by recombinant platelet factor 4 in humans.

17 June 2024

26

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Effects of a heparin-binding protein on blood coagulation and platelet function.

17 June 2024

27

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

CXCR3-mediated opposite effects of CXCL10 and CXCL4 on T1 or T2 cytokine production

17 June 2024

28

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

4q loss is potentially an important genetic event in MM tumorigenesis: identification of a tumor suppressor gene regulated by promoter methylation at 4q13.3, platelet factor 4.

17 June 2024

29

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Pharmacotherapy of heparin- induced thrombocytopenia

17 June 2024

30

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Immune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion.

17 June 2024

32

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions

17 June 2024

33

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds IL-8: novel mechanisms for modulation of hematopoiesis

17 June 2024

34

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells

17 June 2024

35

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Stimulation of angiostatic platelet factor-4 variant (CXCL4L1/PF-4var) versus inhibition of angiogenic granulocyte chemotactic protein-2 (CXCL6/GCP-2) in normal and tumoral mesenchymal cells

17 June 2024

36

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Platelet-associated PF-4 as a biomarker of early tumor growth

17 June 2024

37

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

Platelet factor 4 is highly upregulated in dendritic cells after severe trauma

17 June 2024

38

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2010-03-274852

17 June 2024

Identifiers

1 reference

13 September 2017

1 reference